Search

for
Search:

Research

5 / 1000+ results

Chronic Telogen Effluvium and Female Pattern Hair Loss Are Separate and Distinct Forms of Alopecia: A Histomorphometric and Immunohistochemical Analysis

research Chronic telogen effluvium and female pattern hair loss are separate and distinct forms of alopecia: a histomorphometric and immunohistochemical analysis

8 citations , August 2014 in “Clinical and Experimental Dermatology”

CTE and FPHL are different hair loss types with unique causes.

Telogen Effluvium: A Study on Hair Loss and Its Causes

research Telogen effluvium

October 2005 in “CRC Press eBooks”

Telogen effluvium is a condition where hair falls out due to various factors like illness, stress, or nutrient deficiency.

research Telogen effluvium. New concepts and review

69 citations , March 1993 in “Archives of Dermatology”

The document says there are five types of hair loss conditions and different causes, including drugs.

research Telogen effluvium: acute and chronic

November 2001 in “CRC Press eBooks”

Hair loss from telogen effluvium happens when a disturbance or imbalance causes hair to fall out prematurely.

research Study on Effect of Constant-release Melatonin on SOX21 Gene

January 2011 in “China Animal Husbandry & Veterinary Medicine”

Constant-release melatonin reduces SOX21 gene expression in goats during the hair follicle resting phase.

View more "telogen release" in research →

Community Join

5 / 779 results

community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

in Treatment 120 upvotes 1 year ago

Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

community I hope ET-02 or PP405 will be released in the next 4-5 years

in Product 15 upvotes 1 year ago

PP405 is a potential hair loss treatment that may work by blocking signals that cause hair cells to stop growing, requiring daily application for effectiveness. It could serve as an alternative to minoxidil and finasteride, but it is not yet available on the market and may take several years to be released.

community How likely do you think it is for PP405 to come out?

in Research/Science 21 upvotes 10 months ago

PP405 is a potential new hair loss treatment that works through metabolic pathways rather than hormonal ones, with an estimated market release between late 2027 and 2029. Current alternatives to finasteride include minoxidil, pyralutamide, fluridil, and RU58841, with hair transplants also being a viable option.

community Realistically, how much PP405 will cost?

in Treatment 27 upvotes 1 year ago

PP405 is in phase 2 trials for hair loss, with discussions on its cost and effectiveness compared to minoxidil and finasteride. Users are skeptical about its efficacy and timeline, with hopes for market release by 2027.

community Looking for suggestions on vitamins

in Female 6 upvotes 2 years ago

A user is seeking affordable hair vitamins without biotin, already taking zinc and D3+K2, and has been dealing with chronic telogen effluvium since 2013. They previously used Nutrafol Vegan but found it too expensive.

View more "telogen release" in community →